(Q71079028)
Statements
Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate (English)
scientific article published on 01 March 1996
No description defined